ECM Weekly (3 November 2018) -Ā TFFIF, Innovent, Softbank, Zhaogang - Open the IPO Floodgate!
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...
665 Views
Innovent Biologics (äæ”č¾¾ēē©) Post IPO: Hit Our TP, What's Next?
Innovent Biologics was priced at theĀ highĀ end and itĀ started trading yesterday (November 1st). It traded up by 18.5% on the first day and 8% on the...
822 Views
Innovent Biologics IPO First-Day: Take Money off the Table
Despite a recentĀ spell of lacklustre early-stage biotech flotations that have slumpedĀ post-IPO, Innovent Biologics Inc (1801 HK)'s shares popped...
672 Views
Last Week in GER Research: Tencent Backed IPOs, Niu, Innovent Biologics, Babytree and Fujifilm
Below is a recap of the key IPO and event-driven research produced by the Global Equity Research team. This week we highlight a very differentiated...
748 Views
Innovent Biologics (äæ”č¾¾ēē©) IPO:Ā Limited Upside Despite Strong Cornerstones (Part 3)
Innovent BiologicsĀ launched theĀ institutional book building today and intends to raise USD 377 to USD 423 million, with an implied market...
525 Views